Limits...
Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA²LEN surveys.

Bjerg A, Ekerljung L, Middelveld R, Dahlén SE, Forsberg B, Franklin K, Larsson K, Lötvall J, Olafsdóttir IS, Torén K, Lundbäck B, Janson C - PLoS ONE (2011)

Bottom Line: The prevalence of any wheeze last 12 months decreased from 20% to 16% (p<0.001), and the prevalence of "asthma-related symptoms" was unchanged at 7%.Past and present smoking decreased.The fact that wheeze did not increase despite the significant increment in rhinitis, may at least in part be due to the decrease in smoking.

View Article: PubMed Central - PubMed

Affiliation: The OLIN Studies, Department of Medicine, Sunderby Central Hospital of Norrbotten, Luleå, Sweden. anders.bjerg@lung.umu.se

ABSTRACT

Background: The increase in asthma prevalence until 1990 has been well described. Thereafter, time trends are poorly known, due to the low number of high quality studies. The preferred method for studying time trends in prevalence is repeated surveys of similar populations. This study aimed to compare the prevalence of asthma symptoms and their major determinants, rhinitis and smoking, in Swedish young adults in 1990 and 2008.

Methods: In 1990 the European Community Respiratory Health Survey (ECRHS) studied respiratory symptoms, asthma, rhinitis and smoking in a population-based sample (86% participation) in Sweden. In 2008 the same symptom questions were included in the Global Allergy and Asthma European Network (GA(2)LEN) survey (60% participation). Smoking questions were however differently worded. The regions (Gothenburg, Uppsala, Umeå) and age interval (20-44 years) surveyed both in 1990 (n = 8,982) and 2008 (n = 9,156) were analysed.

Results: The prevalence of any wheeze last 12 months decreased from 20% to 16% (p<0.001), and the prevalence of "asthma-related symptoms" was unchanged at 7%. However, either having asthma attacks or using asthma medications increased from 6% to 8% (p<0.001), and their major risk factor, rhinitis, increased from 22% to 31%. Past and present smoking decreased.

Conclusion: From 1990 to 2008 the prevalence of obstructive airway symptoms common in asthma did not increase in Swedish young adults. This supports the few available international findings suggesting the previous upward trend in asthma has recently reached a plateau. The fact that wheeze did not increase despite the significant increment in rhinitis, may at least in part be due to the decrease in smoking.

Show MeSH

Related in: MedlinePlus

Adjusted population attributable fractions (aPAF).Fractions (%) including their 95% confidence intervals of any wheeze, “asthma-related symptoms” and “current asthma” in the population attributable to rhinitis and smoking, adjusted also for age (20–27, 28–35, 36–44 years), sex and study centre by multiple logistic regression analysis.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3040758&req=5

pone-0016082-g004: Adjusted population attributable fractions (aPAF).Fractions (%) including their 95% confidence intervals of any wheeze, “asthma-related symptoms” and “current asthma” in the population attributable to rhinitis and smoking, adjusted also for age (20–27, 28–35, 36–44 years), sex and study centre by multiple logistic regression analysis.

Mentions: Adjusted population attributable fractions (aPAF) were calculated from multivariate ORs and risk factor prevalence (Figure 4). For any wheeze, in 1990 rhinitis and current smoking each had aPAF around 25% whereas in 2008, aPAF was 40% for rhinitis and 10% for smoking. This pattern was seen also for “asthma-related symptoms”, only with greater aPAF of rhinitis in both surveys. For “current asthma”, the aPAF of rhinitis was around 60% in both surveys while that of smoking was negligible.


Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA²LEN surveys.

Bjerg A, Ekerljung L, Middelveld R, Dahlén SE, Forsberg B, Franklin K, Larsson K, Lötvall J, Olafsdóttir IS, Torén K, Lundbäck B, Janson C - PLoS ONE (2011)

Adjusted population attributable fractions (aPAF).Fractions (%) including their 95% confidence intervals of any wheeze, “asthma-related symptoms” and “current asthma” in the population attributable to rhinitis and smoking, adjusted also for age (20–27, 28–35, 36–44 years), sex and study centre by multiple logistic regression analysis.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3040758&req=5

pone-0016082-g004: Adjusted population attributable fractions (aPAF).Fractions (%) including their 95% confidence intervals of any wheeze, “asthma-related symptoms” and “current asthma” in the population attributable to rhinitis and smoking, adjusted also for age (20–27, 28–35, 36–44 years), sex and study centre by multiple logistic regression analysis.
Mentions: Adjusted population attributable fractions (aPAF) were calculated from multivariate ORs and risk factor prevalence (Figure 4). For any wheeze, in 1990 rhinitis and current smoking each had aPAF around 25% whereas in 2008, aPAF was 40% for rhinitis and 10% for smoking. This pattern was seen also for “asthma-related symptoms”, only with greater aPAF of rhinitis in both surveys. For “current asthma”, the aPAF of rhinitis was around 60% in both surveys while that of smoking was negligible.

Bottom Line: The prevalence of any wheeze last 12 months decreased from 20% to 16% (p<0.001), and the prevalence of "asthma-related symptoms" was unchanged at 7%.Past and present smoking decreased.The fact that wheeze did not increase despite the significant increment in rhinitis, may at least in part be due to the decrease in smoking.

View Article: PubMed Central - PubMed

Affiliation: The OLIN Studies, Department of Medicine, Sunderby Central Hospital of Norrbotten, Luleå, Sweden. anders.bjerg@lung.umu.se

ABSTRACT

Background: The increase in asthma prevalence until 1990 has been well described. Thereafter, time trends are poorly known, due to the low number of high quality studies. The preferred method for studying time trends in prevalence is repeated surveys of similar populations. This study aimed to compare the prevalence of asthma symptoms and their major determinants, rhinitis and smoking, in Swedish young adults in 1990 and 2008.

Methods: In 1990 the European Community Respiratory Health Survey (ECRHS) studied respiratory symptoms, asthma, rhinitis and smoking in a population-based sample (86% participation) in Sweden. In 2008 the same symptom questions were included in the Global Allergy and Asthma European Network (GA(2)LEN) survey (60% participation). Smoking questions were however differently worded. The regions (Gothenburg, Uppsala, Umeå) and age interval (20-44 years) surveyed both in 1990 (n = 8,982) and 2008 (n = 9,156) were analysed.

Results: The prevalence of any wheeze last 12 months decreased from 20% to 16% (p<0.001), and the prevalence of "asthma-related symptoms" was unchanged at 7%. However, either having asthma attacks or using asthma medications increased from 6% to 8% (p<0.001), and their major risk factor, rhinitis, increased from 22% to 31%. Past and present smoking decreased.

Conclusion: From 1990 to 2008 the prevalence of obstructive airway symptoms common in asthma did not increase in Swedish young adults. This supports the few available international findings suggesting the previous upward trend in asthma has recently reached a plateau. The fact that wheeze did not increase despite the significant increment in rhinitis, may at least in part be due to the decrease in smoking.

Show MeSH
Related in: MedlinePlus